WeVote

Bill

Bill

HCR 178

RECOGNIZING FEBRUARY 3 AS TOPICAL STEROID WITHDRAWAL SYNDROME AWARENESS DAY.

2025 Regular Session Introduced by Jenna Takenouchi

HCR 178 designates February 3 as Topical Steroid Withdrawal Syndrome Awareness Day, promoting education and support for those affected by this condition.

Referred to HLT, CAA, referral sheet 22
0
WeVote Research Nonpartisan
Bill Summary · HCR 178

Summary of HCR 178: Recognizing February 3 as Topical Steroid Withdrawal Syndrome Awareness Day

Purpose and Intent

HCR 178 is a concurrent resolution introduced to officially recognize February 3 as Topical Steroid Withdrawal Syndrome Awareness Day. The intent of this resolution is to raise awareness about Topical Steroid Withdrawal Syndrome (TSWS), a condition that can occur in individuals who have used topical steroids for extended periods. By designating a specific day for awareness, the resolution aims to educate the public, healthcare professionals, and policymakers about the challenges faced by those affected by TSWS.

Key Provisions

  • Recognition of Awareness Day: The resolution formally establishes February 3 as Topical Steroid Withdrawal Syndrome Awareness Day.
  • Promotion of Awareness: It encourages educational initiatives and activities to inform the public about TSWS, its symptoms, and the impact it has on individuals' lives.
  • Support for Affected Individuals: The resolution aims to foster a supportive environment for those suffering from TSWS, promoting understanding and compassion within communities.

Affected Parties

  • Individuals with TSWS: The primary beneficiaries of this resolution are individuals who have experienced or are currently experiencing Topical Steroid Withdrawal Syndrome.
  • Healthcare Providers: The resolution seeks to inform healthcare professionals about TSWS, potentially leading to better diagnosis and treatment options for patients.
  • Advocacy Groups: Organizations focused on skin health and patient advocacy may utilize this awareness day to further their missions and outreach efforts.

Legislative Process and Timeline

  • Introduced: HCR 178 was offered on March 7, 2025.
  • Referral: On March 14, 2025, the resolution was referred to the Health and Long-Term Care (HLT) and Consumer Affairs and Administration (CAA) committees for further consideration.

Related Legislation

  • HR 174: This bill serves as a companion resolution to HCR 178, indicating a parallel effort in the legislative process to recognize and promote awareness of TSWS.

Conclusion

HCR 178 represents a significant step towards increasing awareness of Topical Steroid Withdrawal Syndrome. By designating February 3 as an awareness day, the resolution aims to educate the public and healthcare providers, ultimately supporting those affected by this condition. The resolution's progress through the legislative process will be monitored as it moves through committee review.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.